Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Kidney Neoplasms × Tyrosine Kinase Inhibitors × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 NSCLC 1 Lung Neoplasms 1 Leukemia, Biphenotypic, Acute 1 Gastro Intestinal Stromal Tumor 1 Endometrial Neoplasms 1 Congenital Abnormalities 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Asymptomatic Brain Metastases 1

Interventions

pembrolizumab 14 Nivolumab 12 Ipilimumab 9 cabozantinib 6 Axitinib 6 belzutifan 5 Radiosurgery 5 atezolizumab 3 Sunitinib 3 Radiotherapy 3 Biopsy 3 zimberelimab 2 palbociclib 2 lenvatinib 2 Surveys and Questionnaires 2 Pluvicto 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 trebananib 1 toripalimab 1 tocilizumab 1 temsirolimus 1 talazoparib 1 spartalizumab 1 seribantumab 1 polyethylene glycol 3350 1 pazopanib 1 guadecitabine 1 gallium Ga 68 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡